We found that participants in the MASLD + /NAFLD+ group were more likely to be female than those in the No-SLD group, the prevalence of type 2 diabetes was higher, they were more likely to be non-smokers, and they had higher AST and ALT activities. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.